Literature DB >> 29511049

LPA kringle IV type 2 is associated with type 2 diabetes in a Chinese population with very high cardiovascular risk.

Di-Li-Da-Er Mu-Han-Ha-Li 迪丽达尔 木汗哈力1, Tian-Yu Zhai 翟天羽1, Yan Ling 凌雁2, Xin Gao 高鑫1.   

Abstract

The connection between lipoprotein (a) [Lp(a)] levels and the risks of cardiovascular disease and diabetes remains poorly understood. Lp(a) is encoded by the LPA gene, and evidence suggests that the kringle IV type 2 (KIV-2) variant is particularly important to Lp(a) isoform size. A large isoform size, represented as a high number of KIV-2 repeats in LPA, is associated with low serum Lp(a) concentrations and an increased risk of type 2 diabetes. We investigated the associations among Lp(a) concentrations, LPA KIV-2 repeats, and type 2 diabetes in a Chinese population of 1,863 consecutive patients with very high cardiovascular risk, as identified by coronary angiography. Individuals with Lp(a) levels in the top tertile [67.86 (35.34-318.50) mg/dl] had a lower risk of diabetes compared with those in the bottom tertile [7.38 (0.60-12.91) mg/dl]. There was an inverse association between the number of KIV-2 repeats and serum Lp(a) concentrations. This study demonstrated that a high number of LPA KIV-2 repeats are associated with increased risk of type 2 diabetes in a Chinese population with very high cardiovascular risk, which suggests that large Lp(a) isoform size, associated with low Lp(a) concentration, has a causal effect on type 2 diabetes.
Copyright © 2018 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Mendelian randomization; gene expression; genetics; glucose; lipids; lipoprotein (a); lipoproteins; polymorphisms

Mesh:

Substances:

Year:  2018        PMID: 29511049      PMCID: PMC5928429          DOI: 10.1194/jlr.P082792

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  27 in total

1.  Lipoprotein (a) is a risk factor for coronary artery disease in Chinese Han ethnic population modified by some traditional risk factors: A cross-sectional study of 3462 cases and 6125 controls.

Authors:  Dong-Ping Cai; Yong-Ming He; Xiang-Jun Yang; Xin Zhao; Hai-Feng Xu
Journal:  Clin Chim Acta       Date:  2015-10-17       Impact factor: 3.786

2.  Serum lipoprotein (a) concentrations are inversely associated with T2D, prediabetes, and insulin resistance in a middle-aged and elderly Chinese population.

Authors:  Lin Ding; An Song; Meng Dai; Min Xu; Wanwan Sun; Baihui Xu; Jichao Sun; Tiange Wang; Yu Xu; Jieli Lu; Weiqing Wang; Yufang Bi; Guang Ning
Journal:  J Lipid Res       Date:  2015-02-03       Impact factor: 5.922

3.  Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies.

Authors:  Sotirios Tsimikas; Jennifer L Hall
Journal:  J Am Coll Cardiol       Date:  2012-08-21       Impact factor: 24.094

4.  Copy number variation of the Lipoprotein(a) (LPA) gene is associated with coronary artery disease in a southern Han Chinese population.

Authors:  Zhijun Wu; Haihui Sheng; Yanjia Chen; Jing Tang; Yan Liu; Qiujing Chen; Lin Lu; Wei Jin
Journal:  Int J Clin Exp Med       Date:  2014-10-15

5.  Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.

Authors:  C Sandholzer; E Boerwinkle; N Saha; M C Tong; G Utermann
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

Review 6.  Diabetes and cardiovascular disease. The "common soil" hypothesis.

Authors:  M P Stern
Journal:  Diabetes       Date:  1995-04       Impact factor: 9.461

7.  Determination of lipoprotein(a) kringle repeat number from genomic DNA: copy number variation genotyping using qPCR.

Authors:  Matthew B Lanktree; Chandheeb Rajakumar; J Howard Brunt; Marlys L Koschinsky; Philip W Connelly; Robert A Hegele
Journal:  J Lipid Res       Date:  2008-12-05       Impact factor: 5.922

8.  Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study.

Authors:  Pia R Kamstrup; Marianne Benn; Anne Tybjaerg-Hansen; Børge G Nordestgaard
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690

9.  The association between the LPA gene polymorphism and coronary artery disease in Chinese Han population.

Authors:  Zi-Kai Song; Hai-Di Wu; Hong-Yan Cao; Ling Qin
Journal:  Biomed Res Int       Date:  2014-03-25       Impact factor: 3.411

Review 10.  The metabolic vascular syndrome - guide to an individualized treatment.

Authors:  Markolf Hanefeld; Frank Pistrosch; Stefan R Bornstein; Andreas L Birkenfeld
Journal:  Rev Endocr Metab Disord       Date:  2016-03       Impact factor: 6.514

View more
  7 in total

1.  In search of a physiological function of lipoprotein(a): causality of elevated Lp(a) levels and reduced incidence of type 2 diabetes.

Authors:  Sotirios Tsimikas
Journal:  J Lipid Res       Date:  2018-04-02       Impact factor: 5.922

Review 2.  Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations.

Authors:  Nishant P Shah; Neha J Pajidipati; Robert W McGarrah; Ann Marie Navar; Sreekanth Vemulapalli; Michael A Blazing; Svati H Shah; Adrian F Hernandez; Manesh R Patel
Journal:  Am J Cardiol       Date:  2020-04-07       Impact factor: 2.778

Review 3.  Genetics of Lipoprotein(a): Cardiovascular Disease and Future Therapy.

Authors:  Anne Langsted; Børge G Nordestgaard
Journal:  Curr Atheroscler Rep       Date:  2021-06-20       Impact factor: 5.113

4.  A novel deletion mutation in the LPA gene in a middle-aged woman with ischaemic stroke.

Authors:  Youran Li; Yizhong Wang; Fan Gong; Xiaofei Yu; Ting Zhang
Journal:  BMC Med Genomics       Date:  2021-05-18       Impact factor: 3.063

5.  Elevated lipoprotein(a) and genetic polymorphisms in the LPA gene may predict cardiovascular events.

Authors:  Jun-Xu Gu; Juan Huang; Shan-Shan Li; Li-Hua Zhou; Ming Yang; Yang Li; Ai-Min Zhang; Yue Yin; Na Zhang; Mei Jia; Ming Su
Journal:  Sci Rep       Date:  2022-03-04       Impact factor: 4.379

6.  Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment.

Authors:  Gregory G Schwartz; Michael Szarek; Vera A Bittner; Deepak L Bhatt; Rafael Diaz; Shaun G Goodman; J Wouter Jukema; Megan Loy; Garen Manvelian; Robert Pordy; Harvey D White; Philippe Gabriel Steg
Journal:  Diabetes Care       Date:  2021-03-15       Impact factor: 19.112

Review 7.  Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians.

Authors:  Enas A Enas; Basil Varkey; T S Dharmarajan; Guillaume Pare; Vinay K Bahl
Journal:  Indian Heart J       Date:  2019-05-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.